Douglas RC - Search Results

1

5alpha-reductase type 1 immunostaining is enhanced in some prostate cancers compared with benign prostatic hyperplasia epithelium.

Thomas LN, Douglas RC, Vessey JP, Gupta R, Fontaine D, Norman RW, Thompson IM, Troyer DA, Rittmaster RS, Lazier CB. Thomas LN, et al. Among authors: douglas rc. J Urol. 2003 Nov;170(5):2019-25. doi: 10.1097/01.ju.0000091804.20183.81. J Urol. 2003. PMID: 14532845

2

Levels of 5alpha-reductase type 1 and type 2 are increased in localized high grade compared to low grade prostate cancer.

Thomas LN, Douglas RC, Lazier CB, Gupta R, Norman RW, Murphy PR, Rittmaster RS, Too CK. Thomas LN, et al. Among authors: douglas rc. J Urol. 2008 Jan;179(1):147-51. doi: 10.1016/j.juro.2007.08.155. Epub 2007 Nov 13. J Urol. 2008. PMID: 17997435

3

Type 1 and type 2 5alpha-reductase expression in the development and progression of prostate cancer.

Thomas LN, Douglas RC, Lazier CB, Too CK, Rittmaster RS, Tindall DJ. Thomas LN, et al. Among authors: douglas rc. Eur Urol. 2008 Feb;53(2):244-52. doi: 10.1016/j.eururo.2007.10.052. Epub 2007 Nov 5. Eur Urol. 2008. PMID: 18006217 Review.

4

Overexpression of 5 alpha-reductase type 1 increases sensitivity of prostate cancer cells to low concentrations of testosterone.

Thomas LN, Douglas RC, Rittmaster RS, Too CK. Thomas LN, et al. Among authors: douglas rc. Prostate. 2009 May 1;69(6):595-602. doi: 10.1002/pros.20911. Prostate. 2009. PMID: 19125422

5

Androgen-induced regrowth in the castrated rat ventral prostate: role of 5alpha-reductase.

Wright AS, Douglas RC, Thomas LN, Lazier CB, Rittmaster RS. Wright AS, et al. Among authors: douglas rc. Endocrinology. 1999 Oct;140(10):4509-15. doi: 10.1210/endo.140.10.7039. Endocrinology. 1999. PMID: 10499505

6

The utility of tissue transglutaminase as a marker of apoptosis during treatment and progression of prostate cancer.

Rittmaster RS, Thomas LN, Wright AS, Murray SK, Carlson K, Douglas RC, Yung J, Messieh M, Bell D, Lazier CB. Rittmaster RS, et al. Among authors: douglas rc. J Urol. 1999 Dec;162(6):2165-9. doi: 10.1016/S0022-5347(05)68153-0. J Urol. 1999. PMID: 10569613

7

Dutasteride, the dual 5alpha-reductase inhibitor, inhibits androgen action and promotes cell death in the LNCaP prostate cancer cell line.

Lazier CB, Thomas LN, Douglas RC, Vessey JP, Rittmaster RS. Lazier CB, et al. Among authors: douglas rc. Prostate. 2004 Feb 1;58(2):130-44. doi: 10.1002/pros.10340. Prostate. 2004. PMID: 14716738

8

Relative potency of testosterone and dihydrotestosterone in preventing atrophy and apoptosis in the prostate of the castrated rat.

Wright AS, Thomas LN, Douglas RC, Lazier CB, Rittmaster RS. Wright AS, et al. Among authors: douglas rc. J Clin Invest. 1996 Dec 1;98(11):2558-63. doi: 10.1172/JCI119074. J Clin Invest. 1996. PMID: 8958218 Free PMC article.

9

Insulin-like growth factor binding protein 5 is associated with involution of the ventral prostate in castrated and finasteride-treated rats.

Thomas LN, Cohen P, Douglas RC, Lazier C, Rittmaster RS. Thomas LN, et al. Among authors: douglas rc. Prostate. 1998 Jun 1;35(4):273-8. doi: 10.1002/(sici)1097-0045(19980601)35:4<273::aid-pros6>3.0.co;2-h. Prostate. 1998. PMID: 9609550

10

Effect of methimazole with or without exogenous L-thyroxine on serum concentrations of thyrotropin (TSH) receptor antibodies in patients with Graves' disease.

Rittmaster RS, Zwicker H, Abbott EC, Douglas R, Givner ML, Gupta MK, Lehmann L, Reddy S, Salisbury SR, Shlossberg AH, Tan MH, York SE. Rittmaster RS, et al. J Clin Endocrinol Metab. 1996 Sep;81(9):3283-8. doi: 10.1210/jcem.81.9.8784084. J Clin Endocrinol Metab. 1996. PMID: 8784084 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters